Amica Mutual Insurance Co. lowered its stake in Aetna Inc. (NYSE:AET) by 29.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,187 shares of the company’s stock after selling 7,729 shares during the period. Amica Mutual Insurance Co.’s holdings in Aetna were worth $2,100,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of AET. Logan Capital Management Inc. increased its stake in shares of Aetna by 2.6% in the first quarter. Logan Capital Management Inc. now owns 5,420 shares of the company’s stock valued at $609,000 after buying an additional 139 shares in the last quarter. First Republic Investment Management Inc. increased its position in Aetna by 244.5% in the first quarter. First Republic Investment Management Inc. now owns 59,852 shares of the company’s stock worth $6,724,000 after buying an additional 42,480 shares during the period. BlueMountain Capital Management LLC increased its position in Aetna by 430.7% in the first quarter. BlueMountain Capital Management LLC now owns 8,756 shares of the company’s stock worth $984,000 after buying an additional 7,106 shares during the period. Summit Financial Wealth Advisors LLC acquired a new position in Aetna during the second quarter worth $246,000. Finally, Fulton Bank N.A. increased its position in Aetna by 1.7% in the second quarter. Fulton Bank N.A. now owns 38,657 shares of the company’s stock worth $4,722,000 after buying an additional 634 shares during the period. 88.28% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Aetna Inc. (NYSE:AET) traded up 2.84% during trading on Tuesday, reaching $132.03. 2,914,015 shares of the company’s stock traded hands. The stock has a market cap of $46.33 billion, a price-to-earnings ratio of 19.04 and a beta of 0.54. Aetna Inc. has a 52-week low of $92.42 and a 52-week high of $132.57. The company’s 50 day moving average is $115.36 and its 200-day moving average is $116.66.

Aetna (NYSE:AET) last posted its earnings results on Thursday, October 27th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.02 by $0.05. Aetna had a net margin of 3.91% and a return on equity of 16.25%. The firm earned $15.78 billion during the quarter, compared to analyst estimates of $15.71 billion. During the same quarter in the prior year, the business posted $1.90 EPS. The business’s revenue was up 5.5% compared to the same quarter last year. On average, analysts anticipate that Aetna Inc. will post $8.02 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Amica Mutual Insurance Co. Lowers Stake in Aetna Inc. (AET)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.thecerbatgem.com/2016/11/29/amica-mutual-insurance-co-lowers-stake-in-aetna-inc-aet.html.

AET has been the subject of a number of analyst reports. Credit Suisse Group AG reaffirmed a “hold” rating and issued a $120.00 target price on shares of Aetna in a research report on Tuesday, August 30th. Leerink Swann reaffirmed an “outperform” rating on shares of Aetna in a research report on Wednesday, August 24th. Evercore ISI initiated coverage on shares of Aetna in a research report on Thursday, September 22nd. They issued a “buy” rating and a $128.00 target price for the company. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $128.00 target price for the company in a research report on Tuesday, October 4th. Finally, Barclays PLC reiterated a “buy” rating and issued a $142.00 price target on shares of Aetna in a research note on Monday, November 7th. Seven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Aetna currently has an average rating of “Buy” and an average target price of $132.14.

In other news, Director Jeffrey E. Garten sold 7,100 shares of the company’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total value of $827,221.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.90% of the stock is currently owned by insiders.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).

5 Day Chart for NYSE:AET

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.